Heather
()
11/07/07 02:49 PM
Bacteria: a new player in gastrointestinal motility disorders-infections, bacterial overgrowth, and probiotics

Gastroenterol Clin North Am. 2007 Sep;36(3):735-48.

Bacteria: a new player in gastrointestinal motility disorders-infections, bacterial overgrowth, and probiotics.

Quigley EM.

Department of Medicine, Alimentary Pharmabiotic Centre, University College Cork, Clinical Sciences Building, Cork University Hospital, Cork, Ireland.

Irritable bowel syndrome (IBS) may result from a dysfunctional interaction between the indigenous flora and the intestinal mucosa, which in turn leads to immune activation in the colonic mucosa. Some propose that bacterial overgrowth is a common causative factor in the pathogenesis of symptoms in IBS; others point to evidence suggesting that the cause stems from more subtle qualitative changes in the colonic flora.

Bacterial overgrowth will probably prove not to be a major factor in what will eventually be defined as IBS. Nevertheless, short-term therapy with either antibiotics or probiotics seems to reduce symptoms among IBS patients. However, in the long term, safety issues will favor the probiotic approach; results of long-term studies with these agents are eagerly awaited.

PMID: 17950446 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17950446&ordinalpos=15&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum



| Privacy statement Help for IBS Home

*
UBB.threads™ 6.2